Get Your Personalized Supplement StackSupplement Stack Quiz

Eicosapentaenoic Acid

Also known as: EPA, 20:5 n-3, timnodonic acid, icosapent, eicosapentaenoic acid ethyl ester, Eicosapentaenoic Acid

Overview

Eicosapentaenoic acid (EPA) is a long-chain omega-3 fatty acid primarily sourced from fatty fish, seafood, and algae. It is essential for various physiological functions, particularly in cardiovascular health and inflammation regulation. EPA works in tandem with docosahexaenoic acid (DHA), sharing significant anti-inflammatory properties that enhance cardiovascular outcomes, particularly in populations with elevated heart disease risk. Robust research underscores its health benefits, which has led to its inclusion in dietary guidelines for heart health. EPA comes in several dietary forms, including fish oil and algal oil supplements, and is known for its role in promoting healthy cell membranes and influencing metabolic processes throughout the body.

Benefits

Eicosapentaenoic acid has extensive cardiovascular benefits, with a meta-analysis of 38 randomized controlled trials suggesting a relative risk reduction in cardiovascular mortality at 0.82. Furthermore, it was associated with decreases in non-fatal myocardial infarctions (0.72) and coronary heart disease events (0.73). Daily intake of 2 to 3 grams is linked to significant blood pressure reductions. The REDUCE-IT trial revealed a 25% relative decrease in adverse cardiovascular events in high-risk patients using EPA. Although there's some evidence indicating potential antioxidant effects, cognitive benefits linked to EPA are less pronounced than those attributed to DHA, suggesting a need for further research in this area.

How it works

Eicosapentaenoic acid is incorporated into cell membranes, impacting their fluidity and altering signaling pathways. It inhibits the synthesis of pro-inflammatory eicosanoids while promoting beneficial mediators like resolvins and protectins. EPA contributes to cardiovascular health by lowering triglycerides, reducing blood pressure, and decreasing platelet aggregation. Known interactions with G protein-coupled receptors and nuclear receptors directly influence inflammatory responses and cellular functionalities throughout the body.

Side effects

Eicosapentaenoic acid is generally well tolerated, though mild gastrointestinal side effects, including fishy aftertaste, nausea, and diarrhea, affect over 5% of users. There is a mild increase in bleeding risk, estimated at 1-5%, particularly with elevated dosages or in individuals with bleeding disorders. Elevated EPA doses have been loosely linked with atrial fibrillation; however, the occurrence remains below 1%. Users on anticoagulant or antiplatelet medications should be cautious due to potential increased bleeding risks. Pregnant or breastfeeding individuals should consult healthcare professionals to safeguard fetal and child health during supplementation.

Dosage

For cardiovascular support, a daily intake of 1-2 grams of eicosapentaenoic acid is frequently recommended, while optimal amounts range from 2 to 3 grams. Doses exceeding 3 grams may elevate side effect risks. Specific timing for supplementation isn’t crucial, but consistent daily intake can optimize health benefits. The triglyceride form of EPA is noted for better absorption compared to its ethyl ester counterpart; this absorption can be enhanced when taken alongside vitamin E.

FAQs

What are the safety risks associated with DHA and EPA?

DHA and EPA are generally safe but can increase bleeding risk and potential atrial fibrillation, particularly at high doses or with EPA monotherapy.

How should I take DHA and EPA supplements?

Consistent daily intake is recommended without specific timing considerations. Triglyceride forms are preferable for better absorption.

When can I expect to see results from DHA and EPA supplementation?

Cardiovascular benefits typically manifest over a period of several months to years of consistent supplementation.

Is there a significant difference between DHA and EPA for health outcomes?

EPA monotherapy has strong cardiovascular benefits, while DHA is crucial for brain health; their combined effects may vary based on health objectives.

Research Sources

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113999/ – This systematic review encompassed 38 randomized controlled trials examining EPA's effects on cardiovascular health, revealing significant reductions in cardiovascular mortality and non-fatal myocardial infarctions believed to stem from increased EPA intake. The analysis confirmed strong evidence supporting EPA's role in heart health.
https://www.nejm.org/doi/full/10.1056/NEJMoa1905297 – The REDUCE-IT trial indicated a 25% reduction in adverse cardiovascular events among high-risk patients treated with EPA. This landmark study emphasized the efficacy of EPA supplementation in improving cardiovascular health and established its potential as a standalone intervention for at-risk populations.